Effects of the ultra-short-acting beta-blocker Esmolol infusion on cardiovascular parameters and quality of postoperative recovery in patients scheduled for elective plastic surgery
Background/Aim: Esmolol is an ultra-short-acting, easily titratable b-adrenergic receptor antagonist used for urgent treatment of hypertension and tachycardia in non-surgical and surgical settings. Aim of this clinical study was to investigate its cardiovascular effects and quality of the emergence...
Guardado en:
Autor principal: | Lončar-Stojiljković Dragana |
---|---|
Formato: | article |
Lenguaje: | EN SR |
Publicado: |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81ef032ae0c341a2b4a97b4e71a2b907 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Traumatic Refractory Ventricular Fibrillation Successfully Treated with Intra-Arrest Esmolol
por: Kevin Raymond, et al.
Publicado: (2021) -
Comparative effects of lidocaine and esmolol in attenuating the hemodynamic response to laryngoscopy and intubation
por: Ram Bhakta Koju, et al.
Publicado: (2017) -
Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
por: Milos Taborsky, et al.
Publicado: (2021) -
Poor tolerance of beta-blockers by elderly patients with heart failure
por: Satoshi Yanagisawa, et al.
Publicado: (2010) -
Current practice of thoracic anaesthesia in Europe – a survey by the European Society of Anaesthesiology Part I – airway management and regional anaesthesia techniques
por: Jerome Defosse, et al.
Publicado: (2021)